Home > Insider Trading > Filing (0001209191-19-046976)

Filing Details

Accession Number:: 0001209191-19-046976
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-08-21 16:16:06
Reporting Period:: 2019-08-19

Accepted Time:: 2019-08-21 16:16:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1339469	Chiasma Inc	CHMA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1586687	Scott Minick	C/O Chiasma, Inc. 460 Totten Pond Rd, Suite 530 Waltham MA 02451		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-19	4,300	$5.02	81,676	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2019-08-20	5,518	$5.33	87,194	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	62,531	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $5.000 to $5.040, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The amounts set forth in Column 5 of the prior Form 4s filed by the Reporting Person incorrectly included 6,844 shares of Common Stock underlying a warrant beneficially owned by the Reporting Person. The amounts in Column 5 of this Form 4 set forth the number of non-derivative securities beneficially owned by the Reporting Person following the reported transactions.
The securities are directly held by the Minick Family Trust ("MFT"). The Reporting Person is the co-trustee of MFT and disclaims beneficial ownership of all the shares except to the extent of his pecuniary interest, if any, therein.
The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $5.310 to $5.358, inclusive. The reporting person undertakes to provide to Chiasma, Inc., any security holder of Chiasma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.